ISR.ST

ISR Immune System Regulation Holding AB (publ) [ISR.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ISR.ST Stock Summary

In the News

ISR.ST Financial details

Company Rating
-
Market Cap
96.61M
Income
-20.7M
Revenue
52K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
23 Feb 2022
P/E
-1.23
Forward P/E
-
PEG
-0.5
P/S
-
P/B
2.51
P/C
-
P/FCF
-1.43
Quick Ratio
3.09
Current Ratio
3.27
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.76
EPS next Y
-
EPS next Q
-
EPS this Y
86.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-138%
ROE
-212%
ROC
-1.99%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.191-9.25
52W High
-
52W Low
-
RSI
-
Rel Volume
8.31
Avg Volume
250.75K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.441005
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
ABEA.DE
ABEC.DE
LLY.SW
VFINX
AVGO
Same Sector
HTBX
000766.SZ
GTBIF
TLRY.TO
GOSS
Check Those
REW
0QW1.L
0677.HK
ECO.OL
000410.SZ
Similar Market Cap
OPNT
RESP
CGV
8237.HK
AEF.MI

Company Profile

Healthcare Biotechnology
  • Volume Average 250.75K
  • Market Capitalization 96.61M
  • Employee 5
  • CEO Prof. Ola S. Winqvist M.D., Ph.D.
  • Headquarters Stockholm,SE
  • IPO Date 2017-03-24
  • Website https://israb.se

ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden.